Optical coherence tomography markers—like the ellipsoid zone—are reshaping clinical trials in intermediate age-related ...

Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist ...

Xeris Biopharma Holdings is a company that has successfully launched products which are already generating revenue. Read why ...

Eli Lilly has agreed to acquire Verve Therapeutics for up to $1.3 billion in a deal designed to bolster the buyer’s cardiovascular treatment pipeline with Verve’s gene editing therapies, led by ...

A breakthrough in breast cancer research is showing promising signs in the development of a vaccine for the disease. Anixa Biosciences, Inc. is working with the Cleveland Clinic to ...

The investigational treatment DZD8586 elicited encouraging antitumor activity with manageable toxicity in heavily pretreated ...

The researchers hypothesized that sildenafil would increase oxygen flow to the placenta and to the unborn fetus, reducing ...

The International Agency for Research on Cancer forecasts over 35 million new cancer cases in 2050 globally. The growing ...

While cancelled NIH grants and regulatory uncertainty are less hospitable to clinical research in the U.S., Europe must play ...

BIO International Convention (BIO2025), the world’s largest annual biotech event, will take place from June 16 to 19 (U.S.